Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany

Related articles

1. Optimizing the timing of one or two doses of pneumococcal conjugate vaccines in older adults in the United States: a modeling study

   This article has 3 authors:

   1. Deus Thindwa
   2. Anabelle Wong
   3. Matthieu Domenech de Cellès

2. Saved and lost: The Health impact of routine vaccination and COVID-19-related restrictions in Democratic People’s Republic of Korea (1980–2024), a modelling study

   This article has 8 authors:

   1. Hanul Park
   2. Austin Carter
   3. Young June Choe
   4. Sempungu Joshua Kirabo
   5. Minjae Choi
   6. InBae Sohn
   7. Joon Hee Han
   8. Yo Han Lee

3. National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥ 50 Years in Canada

   This article has 11 authors:

   1. Robert MacTavish
   2. Andreea Slatculescu
   3. Dylan Ermacora
   4. Katarina Vukovojac
   5. Tanner Noth
   6. Natalie Ward
   7. Kathleen Laskoski
   8. Daniela Fleming
   9. Baanu Manoharan
   10. Julie Laroche
   11. Aissatou Fall